Cyrano Partners with Shanghai Newsummit to Develop Treatment for Loss of Smell

Cyrano Therapeutics of Washington DC has established a partnership with Shanghai Newsummit Biopharma for China development of theophylline, Cyrano's intranasal therapy to treat loss of smell. Newsummit will provide Cyrano, which will establish a subsidiary in China, with regulatory, clinical and market development support. Also, Newsummit helped Cyrano raise funds from a pool of private China investment firms. Newsummit is a wholly owned subsidiary of Zhejiang Yatai Pharma, an infectious disease company. More details....

Stock Symbol: (SHE: 002370)

Share this with colleagues:

Original Article: Cyrano Partners with Shanghai Newsummit to Develop Treatment for Loss of Smell

More From BioPortfolio on "Cyrano Partners with Shanghai Newsummit to Develop Treatment for Loss of Smell"

• Related Companies
• Related Events
• Related Clinical Trials
• Related PubMed Entries
• Related Medications